| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 350.57B | 344.99B | 315.03B | 311.84B | 301.37B | 292.35B |
| Gross Profit | 40.74B | 40.02B | 33.70B | 28.07B | 25.85B | 19.56B |
| EBITDA | 31.02B | 30.33B | 24.63B | 21.51B | 18.68B | 12.53B |
| Net Income | 12.35B | 14.05B | 11.35B | 8.30B | 7.99B | 4.84B |
Balance Sheet | ||||||
| Total Assets | 287.76B | 289.70B | 277.06B | 266.02B | 257.76B | 258.80B |
| Cash, Cash Equivalents and Short-Term Investments | 61.17B | 66.40B | 70.03B | 69.38B | 59.09B | 63.40B |
| Total Debt | 57.52B | 60.85B | 68.20B | 74.56B | 75.38B | 89.03B |
| Total Liabilities | 138.26B | 139.27B | 140.97B | 142.22B | 144.47B | 154.00B |
| Stockholders Equity | 145.75B | 146.78B | 133.27B | 121.30B | 110.93B | 102.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.30B | 10.04B | 14.24B | 8.81B | 1.80B |
| Operating Cash Flow | 0.00 | 23.47B | 17.69B | 18.79B | 16.75B | 14.46B |
| Investing Cash Flow | 0.00 | -16.65B | -7.84B | -5.85B | -6.38B | -10.93B |
| Financing Cash Flow | 0.00 | -13.19B | -9.90B | -3.55B | -15.49B | 31.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥162.72B | 9.98 | ― | 3.65% | 7.73% | -19.90% | |
68 Neutral | ¥992.58B | 10.15 | 9.97% | 3.54% | 12.46% | -3.12% | |
67 Neutral | ¥310.45B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
66 Neutral | ¥323.91B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥331.89B | 20.24 | ― | 1.28% | 8.11% | -9.27% | |
53 Neutral | ¥924.47B | 310.63 | ― | 2.99% | 4.96% | 1.67% |